XML 45 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Consolidated Statements of Operations    
Revenue (including related party revenue of $171,683 and $194,641, respectively) $ 22,184,112 $ 8,502,892
Cost of revenue (including related party costs of $1,363,905 and $2,082,367, respectively) 14,909,389 6,138,363
Gross profit 7,274,723 2,364,529
Operating expenses:    
Sales and marketing 472,213 82,904
Product development (including related party expense of $162,102 and $235,444, respectively) 1,152,433 299,512
Amortization of intangibles 2,741,008 686,691
Impairment expense 2,530,325 0
General and administrative (including share-based compensation expense of $5,400,975 and $3,212,772, respectively, and related party expenses of $132,253 and $438,320, respectively) 17,323,695 8,033,685
Total operating expenses 24,219,674 9,102,792
Loss from operations (16,944,951) (6,738,263)
Other income (expenses):    
Interest expense (including related party interest expense of $30,466 and $12,276, respectively) (3,137,050) (2,022,113)
Initial derivative expense (3,585,983) (3,340,554)
Change in derivative value due to anti-dilution adjustments 0 (2,642,175)
Change in fair value of derivative liability 7,315,580 (2,658,261)
Forgiveness of debt income 24,925 376,177
Grant income 3,382 10,768
Net recognized loss on marketable securities (1,424) (22,416)
Other expense (9,094) 0
Total other income (expenses) 610,336 (10,298,574)
Loss before income taxes (16,334,615) (17,036,837)
Net loss $ (16,334,615) $ (17,036,837)
Net loss per common share - basic and diluted $ 1.90 $ 8.75
Weighted average common shares - basic and diluted 8,601,159 1,949,463